CSS
RVLP

Cubist Systematic Strategies’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Cubist Systematic Strategies’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-48,558
Closed -$4.21K – 4263
2023
Q3 		$4.21K Buy
+48,558
New +$14K ﹤0.01% 3177
2020
Q3 		– Sell
-12,212
Closed -$82K – 2690
2020
Q2 		$82K Buy
12,212
+629
+5% +$3.08K ﹤0.01% 2226
2020
Q1 		$37K Buy
+11,583
New +$61.7K ﹤0.01% 2031

Other funds holding RVLP

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Cubist Systematic Strategies's RVLP Position: Q4 2023 in Review

Cubist Systematic Strategies sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 48,558 shares — an estimated $4.21K sold.

Cubist Systematic Strategies first reported a position in RVLP in Q1 2020 and held it in 3 quarters. The position peaked at $82K in Q2 2020. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.

  • Cubist Systematic Strategies reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 48,558 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $4.21K.
  • Cubist Systematic Strategies first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2020 and held it in 3 quarters.
  • Cubist Systematic Strategies's RVL Pharmaceuticals plc Ordinary Shares position peaked at $82K in Q2 2020.
  • 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.

Based on Cubist Systematic Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.